MADE in America Act

Cost and committee reports

Official records Congress.gov attaches to H.R. 2707.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Mr. CARTER of Georgia, as printed in the Congressional Record (Vol. 169, No. 65, April 19, 2023, Page H1887):
  Article 1, Section 8 of the Constitution The single subject of this legislation is: To mitigate drug shortages and provide incentives for maintaining, expanding, and relocating the manufacturing of active pharmaceutical ingredients, excipients, medical diagnostic devices, pharmaceuticals, and personal protective equipment in the United States, and for other purposes.
  Source: Congress.gov, Congressional Record April 19, 2023 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  369 characters

  Congress.gov bill record

  H.R. 2707, 118th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/118/hr/2707

  Record last updated by Congress.gov

  December 21, 2024

  PORKER copy retrieved

  September 14, 2026

  Stored copy, SHA-256 of the file

  7e2cfde7a91387952c093dd11dae8af50087211f0420c96c0b6ff90ce0b0ea66

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of December 21, 2024). Not every bill gets one.

From the Congress.gov bill record for H.R. 2707, last updated December 21, 2024. PORKER’s copy was retrieved September 14, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.